مقایسهٔ روشها
روشهای انتخابی خود را کنار هم مرور کنید؛ ردیفهای متفاوت برجسته شدهاند.
| TED-QoL / GO-QoL: پرسشنامه کیفیت زندگی در بیماری چشمی تیروئید× | ThyPRO: مقیاس پیامدهای گزارششده توسط بیمار مرتبط با تیروئید× | |
|---|---|---|
| حوزه | غدد درونریز | غدد درونریز |
| خانواده | Process / pipeline | Process / pipeline |
| سال پیدایش≠ | 2001 | 2009 |
| پدیدآور≠ | Caroline Terwee, Markus Gerding, Frank Dekker | Torquil Watt, Jens Bjørner, Marianne Groenvold |
| نوع | Patient self-report questionnaire | Patient self-report questionnaire |
| منبع بنیادین≠ | Terwee, C. B., Gerding, M. N., Dekker, F. W., et al. (2001). Development of a disease-specific questionnaire for patients with Graves' ophthalmopathy: The GO-QoL. Br J Ophthalmol, 82(7), 773-779. link ↗ | Watt, T., Bjorner, J. B., Groenvold, M., et al. (2009). Establishing construct validity for the thyroid-related patient reported outcomes (ThyPRO): An initial examination. J Clin Endocrinol Metab, 94(9), 3572-3580. link ↗ |
| نامهای دیگر | GO-QoL, Graves Ophthalmopathy Quality of Life | ThyPRO-85, ThyPRO-39 |
| مرتبط | 3 | 3 |
| خلاصه≠ | The TED-QoL (also known as GO-QoL, Graves' Ophthalmopathy Quality of Life questionnaire) is a 16-item disease-specific instrument assessing quality of life impacts in patients with thyroid eye disease (TED), the ophthalmologic manifestation of Graves' disease. Developed by Terwee, Gerding, and colleagues in 2001, it captures both functional vision limitations and psychological distress related to the characteristic eye changes (exophthalmos, lid retraction, diplopia, appearance concerns). It is the gold-standard outcome measure for TED quality of life assessment. | ThyPRO is a comprehensive patient-reported outcome measure assessing the quality of life impact of thyroid disease and its treatment across 13 dimensions. Developed by Watt and colleagues in 2009, it is the most extensively validated thyroid-specific instrument, covering both physical and psychological domains relevant to patients with hyperthyroidism, hypothyroidism, and thyroid cancer. |
| ScholarGateمجموعهداده ↗ |
|
|